Victrix Investment Advisors’s Eli Lilly LLY Stock Holding History

Victrix Investment Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.5M	Sell	1,253 -69	-5%	-$70.5K	0.63%	40
2026 Q1	$1.22M	Buy	1,322 +44	+3%	+$44.6K	0.44%	56
2025 Q4	$1.37M	Sell	1,278 -16	-1%	-$15.3K	0.53%	53
2025 Q3	$987K	Sell	1,294 -1	-0.1%	-$744	0.54%	43
2025 Q2	$1.01M	Buy	1,295 +733	+130%	+$570K	0.45%	55
2025 Q1	$514K	Sell	562 -650	-54%	-$541K	0.27%	63
2024 Q4	$936K	Buy	+1,212	New	+$1M	0.67%	36

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Victrix Investment Advisors's LLY Position: Q2 2026 in Review

Victrix Investment Advisors reduced its Eli Lilly (LLY) stake by 5.2% in Q2 2026, selling an estimated $70.5K and leaving 1,253 shares worth $1.5M. The position accounts for 0.63% of the portfolio, ranked #40.

Victrix Investment Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,984 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Victrix Investment Advisors held 1,253 shares of Eli Lilly worth $1.5M as of Q2 2026.
Victrix Investment Advisors sold 69 Eli Lilly shares in Q2 2026, an estimated $70.5K.
Eli Lilly made up 0.63% of Victrix Investment Advisors's portfolio in Q2 2026, its #40 holding.
Victrix Investment Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
1,984 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Victrix Investment Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.